tenofovir alafenamide (Vemlidy)
Jump to navigation
Jump to search
Introduction
see tenofovir.
Notes
- novel formulation of tenofovir alafenamide
- tenofovir alafenamide is a component of Genvoya
- may be associated with less nephrotoxicity & less effects on bone mineral density than tenofovir disoproxil fumarate[1]
References
- ↑ Jump up to: 1.0 1.1 FDA News Release. November 5, 2015 FDA approves new treatment for HIV http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm471300.htm